Increased detection rates of EGFR and KRAS mutations in NSCLC specimens with low tumour cell content by 454 deep sequencing
Evgeny A. Moskalev(Friedrich-Alexander-Universität Erlangen-Nürnberg), Florian Haller(Universitätsklinikum Erlangen), Helmut König(Johannes Gutenberg University Mainz), Florian Fuchs(Friedrich-Alexander-Universität Erlangen-Nürnberg), Sergey Mastitsky(German Cancer Research Center), Carsten Boltze(SRH Wald-Klinikum Gera), Simone Hebele(Friedrich-Alexander-Universität Erlangen-Nürnberg), Arndt Hartmann(Friedrich-Alexander-Universität Erlangen-Nürnberg), Robert Stöhr(Friedrich-Alexander-Universität Erlangen-Nürnberg), Horia Sı̂rbu(Universitätsklinikum Erlangen), Ralf J. Rieker(Friedrich-Alexander-Universität Erlangen-Nürnberg), Abbas Agaimy(Comprehensive Cancer Center Erlangen)
Archiv für Pathologische Anatomie und Physiologie und für Klinische Medicin
March 6, 2013
Cited by 34
Related Papers
Comprehensive Transcriptional Analysis of Early-Stage Urothelial Carcinoma
|Cancer Cell|2016|660
Patterns of p53 Mutations Separate Ovarian Serous Borderline Tumors and Low- and High-grade Carcinomas and Provide Support for a New Model of Ovarian Carcinogenesis
|The American Journal of Surgical Pathology|2005|411
The Characteristics of 50 Hospitalized COVID-19 Patients With and Without ARDS
|Deutsches Ärzteblatt international|2020|258
New developments in existing WHO entities and evolving molecular concepts: The Genitourinary Pathology Society (GUPS) update on renal neoplasia
|Modern Pathology|2021|254
The MicroRNA Profile of Prostate Carcinoma Obtained by Deep Sequencing
|Molecular Cancer Research|2010|227